Tin tức & Cập nhật

Chỉ hiển thị Multimedia
MDT without ADT delays systemic therapy initiation in recurrent prostate cancer MDT without ADT delays systemic therapy initiation in recurrent prostate cancer

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer

21 Nov 2022 bởiStephen Padilla

In patients with solitary metastatic recurrences of prostate cancer, metastasis-directed therapy (MDT without androgen deprivation therapy (ADT) can lead to delayed initiation of systemic therapy, according to a study.

21 Nov 2022